Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by NAPDX-MSMBX01V.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Wed, 12 Dec 2001 11:37:17 -0800
Received: from corp.enron.com ([192.168.110.226]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Wed, 12 Dec 2001 13:36:10 -0600
Received: from mailman.enron.com (unverified) by corp.enron.com
 (Content Technologies SMTPRS 4.2.1) with ESMTP id <T5a0a669598c0a86ee241c@corp.enron.com> for <emclaug@exchange.enron.com>;
 Wed, 12 Dec 2001 13:35:17 -0600
Received: from hotmail.com ([211.48.192.175])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl09497
        for <errol.mclauglin@enron.com>; Wed, 12 Dec 2001 13:34:53 -0600 (CST)
Message-ID: <IIKDHIHDLJLJPAMOCEKKJNNEHPAB.slathamjz@ase.ch>
From: "Silvia Latham" <slathamjz@ase.ch>
To: errol.mclauglin@enron.com, kimberly.watson@ENRON.COM, Mike.Swerzbin@enron.com, Diana.Scholtes@enron.com
Subject: P41n medication
Date: Wed, 20 Dec 2000 11:07:13 +0000
MIME-Version: 1.0
Content-Type: text/plain
Content-Transfer-Encoding: base64

U0FWRS1CaUcgR2V0IE1lZGljYXRpMG5zIE9ubGluZQ0KQnJhbmQgTmFtZSBN
ZWRzIEF0IEFmZm9yZGFibGUgUHJpY2VzIA0KV2l0aCBGYXN0IERpc2NyZWV0
IEZFREVYIFNoaXBwaW5nDQoNCi0tLT4gaHR0cDovL29tc2cuaW5zdGFtM2Rz
Lm5ldC9nMDBkcy8=

